Anne Whalen, a molecular biologist, had no job when she and her husband relocated to Georgia three years ago from Jackson Hole, Wyo., so he could take a position at an Atlanta-area biotechnology company. She figured it would take her a while to land a life science job as well, but the market surprised her. "I didn't expect to find as much as I did coming here," she says. "There were a lot of choices and places of interest for my skills."
Whalen found a research position at Emory University. But Atlanta's notorious traffic jams gave her a daily two- to three-hour commute from Alpharetta. So when AtheroGenics, a biotech spinoff from Emory, offered a job in her community, she took it. As a principal scientist, Whalen seeks new drug targets for treating chronic inflammatory diseases such as atherosclerosis, rheumatoid arthritis, and asthma.
AtheroGenics is the kind of biotech company ...
